Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting The Process For Bringing Ultra-Low Temperature Cryoablation for Ventricular Arrhythmias to US Market

/PRNewswire/ -- Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT),...

Related Keywords

San Francisco ,California ,United States ,University Of Arizona ,Arizona ,Canada ,University Medical Center ,Phoenix ,Laguna Hills ,Olav Bergheim ,Edward Gerstenfeld ,William Stevenson ,Vivek Reddy ,Roderick Tung ,University Of California ,Banner Health ,University Medicine ,Adagio Medical Inc ,Vanderbilt University Hospital In Nashville ,University Of Arizona College Medicine ,Twitter ,Linkedin ,University Medical Center Phoenix ,Prnewswire Adagio Medical Inc ,Ultra Low Temperature Cryoablation ,Recurring Monomorphic Ventricular Tachycardia ,Medical Center ,Division Chief ,Cardiovascular Clinical Research ,Internal Medicine ,Arizona College ,Vanderbilt University Hospital ,Mount Sinai Hospital ,World Report ,Adagio Medical ,Fjord Ventures ,Nc ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Clinical Trials Amp Medical Discoveries ,